TickerFacts.

A business in context

CNTB research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001835268-26-000028

  2. 8-K · Current report

    Report date 2026-08-12 · 0001835268-26-000027 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-06-30 · 0001835268-26-000022

  4. 4 · Ownership change

    Report date 2026-06-30 · 0001835268-26-000021

  5. 4 · Ownership change

    Report date 2026-05-29 · 0001193125-26-253607

  6. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001835268-26-000020

  7. 8-K · Current report

    Report date 2026-05-12 · 0001835268-26-000019 · Items 2.02,9.01

  8. 8-K · Current report

    Report date 2026-04-23 · 0001835268-26-000016 · Items 7.01,8.01,9.01

  9. 4 · Ownership change

    Report date 2026-03-31 · 0002115875-26-000004

  10. 4 · Ownership change

    Report date 2026-03-31 · 0001241357-26-000004

  11. 4 · Ownership change

    Report date 2026-03-31 · 0001193125-26-138012

  12. 10-K · Annual report

    Report date 2025-12-31 · 0001835268-26-000013

  13. 8-K · Current report

    Report date 2026-03-31 · 0001835268-26-000012 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-03-29 · 0001835268-26-000006 · Items 1.01,3.02,7.01,8.01,9.01

  15. 8-K · Current report

    Report date 2025-12-17 · 0001835268-25-000061 · Items 5.02,9.01

  16. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001835268-25-000058

  17. 8-K · Current report

    Report date 2025-11-12 · 0001835268-25-000057 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2025-09-16 · 0001835268-25-000056 · Items 7.01

  19. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001835268-25-000052

  20. 8-K · Current report

    Report date 2025-08-13 · 0001835268-25-000051 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-07-22 · 0001835268-25-000047 · Items 5.02,9.01

  22. 8-K · Current report

    Report date 2025-07-18 · 0001835268-25-000044 · Items 1.02,9.01

  23. 8-K · Current report

    Report date 2025-07-16 · 0001835268-25-000039 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-07-09 · 0001628280-25-034551 · Items 7.01,8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001835268-25-000035

  26. 8-K · Current report

    Report date 2025-05-15 · 0001835268-25-000033 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-05-14 · 0001835268-25-000029 · Items 7.01,8.01

  28. 8-K · Current report

    Report date 2025-05-13 · 0001835268-25-000026 · Items 7.01,8.01

  29. 8-K · Current report

    Report date 2025-04-01 · 0001835268-25-000019 · Items 7.01,8.01,9.01

  30. 10-K · Annual report

    Report date 2024-12-31 · 0001835268-25-000014

  31. 8-K · Current report

    Report date 2025-03-31 · 0001835268-25-000013 · Items 2.02,9.01

  32. 6-K · Current report

    Report date 2025-03-28 · 0001835268-25-000008

  33. 6-K · Current report

    Report date 2024-12-10 · 0001628280-24-052323

  34. 6-K · Current report

    Report date 2024-09-06 · 0001835268-24-000027

  35. 6-K · Current report

    Report date 2024-06-30 · 0001835268-24-000023

  36. 6-K · Current report

    Report date 2024-08-02 · 0001835268-24-000019

  37. SC 13D/A · Ownership disclosure

    0001193125-24-173301

  38. 6-K · Current report

    Report date 2024-06-12 · 0001835268-24-000017

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 0 transaction rows0SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

4 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-29
2026-06-02
Huang JamesP · Purchase
Acquired
Ordinary Shares150000.02.48
2026-03-31
2026-04-02
Xanthopoulos Kleanthis GabrielA · Grant / award
Acquired
Ordinary Shares2816.00.0
2026-03-31
2026-04-02
LIU JEAN IA · Grant / award
Acquired
Ordinary Shares5061.00.0
2026-03-31
2026-04-01
Huang JamesP · Purchase
Acquired
Ordinary Shares1160000.03.45

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001835268Connect Biopharma Holdings Ltd

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$26.03M$27.71M
    2023-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗